A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy

PURPOSE: To investigate the efficacy and safety of 0.4 mg of tamsulosin in patients with nocturia not responding to 0.2 mg. METHODS: Patients with intractable nocturia after treatment with 0.2 mg of tamsulosin for>1 month were included in a multicenter, prospective, observational, single-arm stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ho Song, Lee, Jeong Woo, Yu, Jihyeong, Cho, Min Chul, Cho, Sung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944788/
https://www.ncbi.nlm.nih.gov/pubmed/31905276
http://dx.doi.org/10.5213/inj.1938076.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944788/
https://www.ncbi.nlm.nih.gov/pubmed/31905276
http://dx.doi.org/10.5213/inj.1938076.038

Ejemplares similares